Glomerular Filtration Rate Calculator

16 min read · Last verified March 2026 · By Michael Lip

Estimate your kidney function using the CKD-EPI 2021 race-free equation. This calculator also shows the MDRD estimate for comparison and classifies results by CKD stage.

GFR Calculator

Enter your serum creatinine level from a recent blood test, along with your age and sex. The calculator uses the CKD-EPI 2021 equation (race-free) recommended by the National Kidney Foundation and the American Society of Nephrology. It also shows the MDRD estimate for comparison.

What Is Glomerular Filtration Rate

The glomerular filtration rate is a measure of how well your kidneys filter waste products from your blood. Specifically, it estimates the volume of blood that passes through the glomeruli (tiny filtering units in the kidneys) per minute, normalized to a standard body surface area of 1.73 square meters. A healthy adult typically has a GFR of 90 to 120 mL/min/1.73 m², though this naturally declines with age.

Your kidneys contain roughly one million nephrons each, and every nephron includes a glomerulus, a cluster of tiny blood vessels where filtration takes place. Blood enters the glomerulus under pressure, and small molecules like water, electrolytes, glucose, and waste products (including creatinine and urea) pass through the glomerular membrane into the tubular system. Larger molecules like proteins and blood cells are retained in the bloodstream. The filtered fluid then passes through the tubules, where the kidneys reabsorb useful substances and secrete additional waste products to form urine.

I have seen many patients confused about why their doctor orders a "GFR" when the lab test only measures creatinine. The answer is that GFR cannot be measured directly from a simple blood draw. Instead, laboratories use mathematical equations (like the CKD-EPI 2021 formula) to estimate GFR from the serum creatinine level, combined with age and sex. This estimated value, called eGFR, appears on most lab reports automatically whenever creatinine is ordered.

The gold standard for measuring GFR directly involves injecting a tracer substance (like inulin or iohexol) and measuring its clearance rate over several hours. This measured GFR (mGFR) is more precise but is rarely done in clinical practice because it is time-consuming, expensive, and invasive. The estimation equations are precise enough for the vast majority of clinical decisions, which is why they are used universally in routine care.

GFR is clinically significant because it is the primary metric used to diagnose and stage chronic kidney disease. A sustained GFR below 60 mL/min/1.73 m² for three or more months defines CKD, regardless of whether other markers of kidney damage are present. The GFR value determines the CKD stage, which in turn guides treatment decisions, medication dosing, and referral timing.

The CKD-EPI 2021 Equation

The CKD-EPI 2021 equation is the current standard for estimating GFR from serum creatinine. It was developed by the Chronic Kidney Disease Epidemiology Collaboration and published in the New England Journal of Medicine in September 2021. This equation replaced the previous CKD-EPI 2009 version, with the most significant change being the removal of the race coefficient.

The equation uses the following formula, which I have implemented in this calculator:

For females with creatinine 0.7 mg/dL or below: eGFR = 142 x (Scr/0.7)^(-0.241) x (0.9938)^Age

For females with creatinine above 0.7 mg/dL: eGFR = 142 x (Scr/0.7)^(-1.200) x (0.9938)^Age

For males with creatinine 0.9 mg/dL or below: eGFR = 142 x (Scr/0.9)^(-0.302) x (0.9938)^Age

For males with creatinine above 0.9 mg/dL: eGFR = 142 x (Scr/0.9)^(-1.200) x (0.9938)^Age

Where Scr is serum creatinine in mg/dL and Age is in years. The equation applies the same formula to all patients regardless of race, which was a deliberate decision based on a task force recommendation from the National Kidney Foundation and the American Society of Nephrology.

The removal of race from the equation was driven by both scientific and ethical considerations. The race coefficient in the older CKD-EPI 2009 equation produced higher eGFR values for Black patients, which could delay referral to nephrology and delay listing for kidney transplantation. Studies showed that the race-adjusted equation misclassified many Black patients as having better kidney function than they actually had. The 2021 equation without race was validated across diverse populations and performs comparably to the race-adjusted version in most clinical scenarios.

This calculator also shows the MDRD (Modification of Diet in Renal Disease) estimate for comparison. The MDRD equation was the standard before CKD-EPI and is still used in some settings. The MDRD formula is: eGFR = 175 x (Scr)^(-1.154) x (Age)^(-0.203) x 0.742 (if female). The MDRD equation is less precise than CKD-EPI at higher GFR values (above 60), which is why it has been largely replaced. However, seeing both estimates side by side can be useful for understanding the range of possible values.

CKD Stages and Classification

Chronic kidney disease is classified into five stages based on the GFR value. This staging system was established by the Kidney Disease Improving Global Outcomes (KDIGO) organization and is used worldwide. Understanding your CKD stage helps determine the appropriate level of monitoring, lifestyle changes, and medical interventions.

An important nuance is that a GFR in the G1 or G2 range does not automatically mean there is no kidney disease. CKD at these stages requires additional evidence of kidney damage, such as persistent proteinuria (protein in the urine), hematuria (blood in the urine), abnormal kidney imaging, or a history of kidney transplant. A person with a GFR of 95 but persistent protein in their urine would be classified as CKD stage G1, while a person with the same GFR and no markers of damage has normal kidney function.

Stage G3 is divided into G3a and G3b because the clinical implications differ. Patients in G3a (GFR 45-59) often need only monitoring and lifestyle modifications, while patients in G3b (GFR 30-44) frequently need nephrology involvement, medication adjustments (particularly for drugs cleared by the kidneys), and preparation for potential future kidney replacement therapy.

The KDIGO classification also includes albuminuria categories (A1, A2, A3) that combine with GFR stages to create a complete risk assessment. A patient with G2A3 (GFR 60-89 with severely increased albuminuria) is at higher risk of progression than a patient with G3aA1 (GFR 45-59 with normal albuminuria). This is why a single GFR number does not tell the complete story of kidney health.

GFR declines naturally with age at a rate of approximately 1 mL/min/1.73 m² per year after age 30-40. This means a 70-year-old with a GFR of 65 may have age-appropriate kidney function rather than clinically significant CKD. Some nephrology guidelines suggest applying age-adapted thresholds when interpreting GFR in older adults to avoid overdiagnosis.

Understanding Serum Creatinine

Serum creatinine is the blood test value that feeds into the GFR equation. Creatinine is a waste product produced by the normal breakdown of creatine phosphate in muscle tissue. It is produced at a relatively constant rate and is freely filtered by the glomeruli, which makes it a useful (though imperfect) marker of kidney function.

Normal serum creatinine ranges are approximately 0.7 to 1.2 mg/dL for men and 0.5 to 1.0 mg/dL for women, though these ranges vary between laboratories. The difference between sexes exists because men typically have more muscle mass than women, and more muscle means more creatinine production. This is also why the GFR equations include sex as a variable, to account for the expected difference in baseline creatinine.

Several factors can affect creatinine levels independently of kidney function, which is important to understand when interpreting GFR results. People with significantly above-average muscle mass (bodybuilders, for instance) naturally produce more creatinine, which can make their calculated GFR appear lower than their true kidney function. Conversely, people with very low muscle mass (the elderly, malnourished patients, amputees) produce less creatinine, which can make their GFR appear artificially high.

Diet plays a role as well. Eating a large amount of cooked meat before a blood draw can raise creatinine by 10 to 30% because cooked muscle tissue releases preformed creatinine that is absorbed into the bloodstream. This is why some guidelines recommend avoiding a meat-heavy meal before fasting blood work. Creatine supplements, popular among athletes, are converted to creatinine in the body and can improve levels.

Certain medications interfere with creatinine measurement or secretion. Trimethoprim (an antibiotic) and cimetidine (an acid reducer) block the tubular secretion of creatinine, causing blood levels to rise without any actual change in kidney function. If you are taking these medications, let your doctor know so they can interpret your creatinine and GFR results in context.

For patients where creatinine-based equations are unreliable, cystatin C is an alternative biomarker. Cystatin C is a small protein produced by all nucleated cells at a constant rate and is not significantly affected by muscle mass, diet, or most medications. The CKD-EPI organization has published a cystatin C equation and a combined creatinine-cystatin C equation that may be more precise in certain populations.

Risk Factors for Kidney Disease

Understanding the risk factors for chronic kidney disease helps with both prevention and early detection. The two leading causes of CKD worldwide are diabetes and hypertension, which together account for approximately two-thirds of all CKD cases.

Diabetes damages the kidneys through a process called diabetic nephropathy. Chronically improved blood sugar causes structural changes in the glomeruli, thickening the filtration membrane and increasing its permeability to proteins. The earliest sign is microalbuminuria (small amounts of albumin in the urine), which can progress to overt proteinuria and declining GFR over years to decades. Tight blood sugar control (A1C below 7% for most patients) significantly slows the progression of diabetic kidney disease.

Hypertension damages the kidneys by increasing pressure within the glomerular capillaries. Over time, this improved pressure damages the delicate filtration structures, leading to scarring (glomerulosclerosis) and reduced filtration capacity. The relationship is bidirectional: kidney disease also causes hypertension by impairing the kidneys' ability to regulate fluid balance and the renin-angiotensin system. Blood pressure targets for patients with CKD are typically below 130/80 mmHg.

Other significant risk factors include a family history of kidney disease, age over 60, obesity, smoking, cardiovascular disease, recurrent kidney infections, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs like ibuprofen and naproxen), and autoimmune conditions like lupus. African American, Hispanic, Native American, and Asian American populations have higher rates of CKD, likely due to a combination of genetic predisposition, socioeconomic factors, and disparities in healthcare access.

Acute kidney injury (AKI) is increasingly recognized as a risk factor for future CKD. Even a single episode of AKI that appears to resolve completely can leave subtle kidney damage that increases the risk of chronic problems later. If you have had an episode of AKI (from severe dehydration, sepsis, surgery, or nephrotoxic drugs), periodic monitoring of kidney function is advisable.

When to See a Doctor

Kidney disease is often called a "silent" disease because symptoms typically do not appear until the kidneys have lost a significant amount of function. By the time symptoms like fatigue, swelling, changes in urination, nausea, or itching become noticeable, the disease may be modern. This is why screening with blood tests and urinalysis is so important, especially for people with risk factors.

I recommend seeing a doctor about your kidney function in any of the following situations. If your calculated eGFR falls below 60, schedule an appointment with your primary care provider even if you feel perfectly well. A single low eGFR reading may reflect temporary factors (dehydration, medication effects, recent exercise), but it warrants follow-up testing to determine whether the decline is persistent.

If your eGFR is between 60 and 89, the urgency depends on the context. In a 25-year-old, a GFR of 70 is concerning and should be investigated. In a 75-year-old without diabetes or hypertension and no protein in the urine, a GFR of 70 may represent normal aging. Your doctor will consider the full picture including urine tests, blood pressure, and medical history.

Seek prompt medical attention if you experience symptoms that could indicate kidney failure: severe fatigue, persistent nausea or vomiting, confusion, chest pain, shortness of breath not explained by other conditions, or significantly reduced urine output. These symptoms combined with a very low GFR (below 15) may indicate the need for urgent dialysis.

If you have diabetes or hypertension, ensure that your doctor is checking your kidney function (creatinine, eGFR, and urine albumin) at least annually as part of your routine management. Early detection of kidney involvement allows for interventions like ACE inhibitors or ARBs that can slow progression and protect remaining kidney function.

Improving Kidney Health

While kidney damage from CKD is generally not reversible, there are evidence-based strategies that can slow the progression and protect remaining function. These interventions are most effective when started early, which is another reason why screening and early detection matter so much.

Blood pressure control is the single most impactful intervention for most CKD patients. ACE inhibitors (like lisinopril and enalapril) and ARBs (like losartan and valsartan) are the preferred blood pressure medications for patients with CKD because they reduce intraglomerular pressure and decrease proteinuria beyond their blood-pressure-lowering effect. The SPRINT trial and other studies have shown that targeting a systolic blood pressure below 120-130 mmHg slows GFR decline more effectively than standard targets of 140 mmHg.

For patients with diabetic kidney disease, SGLT2 inhibitors (like dapagliflozin and empagliflozin) have emerged as a major advance in treatment. The DAPA-CKD and EMPA-KIDNEY trials demonstrated that these medications reduce the risk of kidney failure by 30-40%, even in patients without diabetes. They work by reducing hyperfiltration in the glomeruli and have additional benefits for heart failure and cardiovascular risk. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, is another newer option shown to slow CKD progression in diabetic patients.

Dietary modifications are important for kidney health. Reducing sodium intake to below 2,300 mg per day helps control blood pressure and reduces the workload on the kidneys. Protein restriction may be recommended for patients with modern CKD (stages 4-5) to reduce the accumulation of uremic toxins, though the evidence for protein restriction in earlier stages is mixed. Staying well hydrated (typically 1.5 to 2 liters of water per day) supports kidney function, though patients with very low GFR or fluid retention may need to restrict fluids based on their doctor's guidance.

Avoiding nephrotoxic substances is straightforward but critical. NSAIDs (ibuprofen, naproxen, aspirin in high doses) should be avoided or minimized in patients with CKD because they reduce blood flow to the kidneys. Certain herbal supplements and over-the-counter products can be harmful to kidneys, so always check with your doctor before starting new supplements. Contrast dye used in CT scans and certain imaging procedures can cause acute kidney injury in patients with reduced GFR, so make sure your doctor knows your kidney function before ordering these tests.

Regular exercise improves kidney health indirectly by helping control blood pressure, blood sugar, and body weight. Studies have shown that regular physical activity is associated with a 9-15% lower risk of CKD progression. Aim for at least 150 minutes of moderate-intensity exercise per week, as recommended by most clinical guidelines.

Limitations of eGFR Calculations

I believe in being transparent about what this calculator can and cannot do. The eGFR equations, including CKD-EPI 2021, have known limitations that are important to understand when interpreting results.

The equations were developed and validated primarily in adult populations aged 18 and older. They are not validated for children or adolescents, who have different normal ranges for creatinine and GFR. Pediatric nephrologists use separate equations like the Schwartz formula for children.

Extreme body compositions reduce accuracy. Bodybuilders with very high muscle mass will have improved creatinine that makes their eGFR appear lower than reality. Patients with severe malnutrition, sarcopenia (age-related muscle loss), amputations, or paraplegia will have low creatinine that makes their eGFR appear higher than reality. In these populations, cystatin C-based equations or measured GFR may be more appropriate.

The equations assume stable kidney function. If the kidneys are in the process of failing acutely (acute kidney injury), creatinine may be rising rapidly and the eGFR calculated from the current creatinine will overestimate actual function. Similarly, during recovery from AKI, creatinine may be falling and eGFR will underestimate actual function. eGFR equations are designed for chronic, stable states.

Pregnancy affects creatinine levels and GFR. Pregnant women have increased blood volume and GFR, leading to lower creatinine levels. The standard eGFR equations will overestimate kidney function during pregnancy. Obstetric guidelines use different reference ranges for creatinine in pregnant patients.

Very high GFR values (above 120) are reported by CKD-EPI but are not clinically meaningful in the same way as values below 60. The equation is optimized for detecting and staging kidney disease, not for precisely measuring hyperfiltration. If the calculator shows a GFR of 135, it means your kidney function is within the normal range, but the exact number is less precise at this level.

Other Kidney Function Tests

While eGFR from creatinine is the most commonly used measure of kidney function, it is part of a broader panel of tests that together provide a complete picture of kidney health. Understanding these additional tests helps you have more informed conversations with your healthcare provider.

Blood Urea Nitrogen (BUN) measures the amount of urea nitrogen in the blood. Like creatinine, urea is a waste product filtered by the kidneys. However, BUN is less specific to kidney function than creatinine because it is also affected by protein intake, liver function, dehydration, and gastrointestinal bleeding. The normal BUN range is 7-20 mg/dL. The BUN-to-creatinine ratio can help distinguish between prerenal causes of improved creatinine (like dehydration, where the ratio rises above 20:1) and intrinsic kidney disease (where the ratio stays closer to 10-15:1).

Urinalysis is a simple urine test that provides valuable information about kidney function. Protein in the urine (proteinuria) is one of the earliest signs of kidney damage, often appearing before GFR begins to decline. Blood in the urine (hematuria) can indicate glomerulonephritis, kidney stones, or urinary tract infections. The urine specific gravity indicates how well the kidneys are concentrating urine. Glucose in the urine suggests uncontrolled diabetes. A complete urinalysis is inexpensive and can be done as part of a routine checkup.

The Urine Albumin-to-Creatinine Ratio (UACR) is a more specific test for kidney damage than a standard urinalysis. It measures the amount of albumin (a specific protein) relative to creatinine in a spot urine sample. Normal is below 30 mg/g. Moderately increased albuminuria (30-300 mg/g, formerly called microalbuminuria) is an early sign of kidney damage and a major risk factor for cardiovascular disease. Severely increased albuminuria (above 300 mg/g) indicates significant glomerular damage and a high risk of progressive kidney disease.

Cystatin C, as mentioned earlier, is an alternative to creatinine for estimating GFR. It is particularly useful in patients with abnormal muscle mass, unusual diets, or conditions that affect creatinine independently of kidney function. The CKD-EPI organization has published equations using cystatin C alone and creatinine-cystatin C combined. The combined equation (using both markers) has the highest accuracy of any estimation equation, though it requires two separate blood tests, making it more expensive.

A 24-hour urine collection measures the total creatinine excreted in urine over a full day, which can be used to calculate creatinine clearance (a direct measure of kidney filtration). While more cumbersome than a blood test, it provides information not available from spot measurements. It is used when estimating equations are unreliable or when precise measurement matters, such as before chemotherapy dosing or kidney donation evaluation.

Kidney imaging with ultrasound is a non-invasive test that shows kidney size, shape, and structure. Small, scarred kidneys suggest chronic damage, while enlarged kidneys can indicate polycystic kidney disease, obstruction, or acute inflammation. Ultrasound also detects kidney stones, tumors, and urinary tract obstruction. It is often the first imaging test ordered when kidney disease is suspected.

Medications and GFR

Kidney function directly affects how medications are processed and eliminated from the body. Many drugs are cleared by the kidneys, and reduced GFR means slower clearance, which can lead to drug accumulation and toxicity if doses are not adjusted.

Drug dosing adjustments based on GFR are routine in clinical practice. The FDA requires manufacturers to provide dosing guidance for patients with kidney impairment for drugs that are primarily renally cleared. Common medications requiring dose adjustment in CKD include metformin (adjusted below GFR 45, contraindicated below GFR 30 in some guidelines), gabapentin and pregabalin (dose reduction begins at GFR below 60), allopurinol (reduced doses for lower GFR), and many antibiotics including ciprofloxacin, vancomycin, and aminoglycosides.

Certain medications can worsen kidney function and should be used with caution or avoided in patients with reduced GFR. NSAIDs (ibuprofen, naproxen) reduce blood flow to the kidneys and can precipitate acute kidney injury, especially when combined with ACE inhibitors or ARBs and diuretics (the "triple whammy" combination). Proton pump inhibitors (omeprazole, pantoprazole) have been associated with acute interstitial nephritis and chronic kidney disease with long-term use. Lithium can cause chronic tubular damage. Methotrexate toxicity increases dramatically with reduced kidney function.

Contrast dye used in CT scans, angiograms, and other imaging procedures can cause contrast-induced nephropathy (CIN) in patients with reduced GFR, particularly when GFR falls below 30. The risk is highest when large volumes of contrast are used, in patients with diabetes, and in those who are dehydrated. Prevention strategies include IV hydration before and after the procedure and using the minimum necessary contrast volume. In high-risk patients, alternative imaging without contrast (MRI without gadolinium, ultrasound) may be preferred.

If you are managing CKD, maintaining an updated medication list and sharing it with every healthcare provider is important. I recommend asking your pharmacist to screen your medications for kidney-related dosing or safety concerns. Many pharmacies now offer this service automatically when they have your lab results on file.

Diet and Nutrition in Chronic Kidney Disease

Dietary management becomes increasingly important as kidney function declines. The kidneys regulate the balance of several nutrients in the body, and when filtration is impaired, dietary intake of these nutrients may need to be restricted to prevent dangerous accumulations.

Sodium restriction is recommended for virtually all CKD patients because the kidneys' ability to excrete sodium decreases as GFR declines. The standard recommendation is to limit sodium intake to below 2,300 mg per day, with many nephrologists recommending below 2,000 mg for patients with significant hypertension or fluid retention. Reducing sodium intake lowers blood pressure, decreases fluid retention, and reduces proteinuria. The biggest sources of dietary sodium are processed foods, restaurant meals, and canned soups and vegetables. Cooking at home with fresh ingredients and using herbs and spices instead of salt is the most effective way to reduce sodium intake.

Potassium management becomes critical in modern CKD (stages 4 and 5) because the kidneys are the primary route for potassium excretion. Hyperkalemia (improved blood potassium) can cause dangerous cardiac arrhythmias and is one of the most common reasons for emergency dialysis. High-potassium foods that may need to be limited include bananas, oranges, potatoes, tomatoes, avocados, nuts, and many dried fruits. Your nephrologist or renal dietitian can provide specific guidelines based on your blood potassium levels and GFR.

Phosphorus restriction is often necessary starting in CKD stage 3, because the kidneys' ability to excrete phosphorus declines before other electrolyte handling is significantly impaired. Improved phosphorus causes secondary hyperparathyroidism, which leads to bone disease (renal osteodystrophy) and vascular calcification. High-phosphorus foods include dairy products, processed meats, cola beverages, and many processed foods containing phosphorus-based additives. Phosphate binders (medications taken with meals to prevent phosphorus absorption) are commonly prescribed alongside dietary restriction.

Protein intake recommendations vary by CKD stage. In stages 1-3, a normal protein intake (0.8-1.0 g/kg/day) is generally appropriate. In stages 4-5 (pre-dialysis), some guidelines recommend reducing protein intake to 0.6-0.8 g/kg/day to slow the accumulation of uremic toxins and potentially slow CKD progression. Once a patient starts dialysis, protein needs increase because dialysis removes amino acids and proteins, so the recommendation jumps to 1.0-1.2 g/kg/day. Working with a renal dietitian is the best way to navigate these changing requirements.

Fluid intake generally does not need to be restricted until late-stage CKD when the kidneys can no longer regulate fluid balance effectively. In stages 1-3, drinking adequate water (1.5-2 liters per day) supports kidney function. In stages 4-5, fluid restriction may be necessary to prevent edema and fluid overload, with the specific limit determined by your doctor based on your urine output and fluid status.

Frequently Asked Questions

Related Free Tools